Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPLIFY: Apixaban for Treatment of DVT and PE
NCT00643201Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2008
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of apixaban in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Bristol Myers Squibb. Started Jul 2008; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00643201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643201.